Please login to the form below

Not currently logged in
Email:
Password:

OxyContin

This page shows the latest OxyContin news and features for those working in and with pharma, biotech and healthcare.

J&J found liable in first opioid mis-marketing verdict

J&J found liable in first opioid mis-marketing verdict

Purdue, the privately held maker of opioid drug OxyContin, has taken the brunt of the blame for the crisis, but J&J ended up as the sole defendant in the

Latest news

More from news
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    Our agency was responsible for the EU launch of OxyContin and the first sublingual formulation of fentanyl, a powerful opioid that is abused by many drug addicts. ... So we are acutely aware of the devastation caused by the opioid epidemic in the US, and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics